Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

2.

Transverse myelopathy occurring with intrathecal administration of methotrexate and cytarabine chemotherapy: A case report.

Pan Y, Wang C, Wang H, Tao Q, Xiong S, Zhai Z.

Oncol Lett. 2016 Jun;11(6):4066-4068. Epub 2016 May 4.

3.

Anterior lumbosacral polyradiculopathy after intrathecal administration of methotrexate.

Pascual AM, Coret F, Casanova B, Láinez MJ.

J Neurol Sci. 2008 Apr 15;267(1-2):158-61. Epub 2007 Oct 18.

PMID:
17949753
4.

Practice of central nervous system prophylaxis and treatment in acute leukemias in Spain. Prospective registry study.

Sancho JM, Morgades M, Arranz R, Fernández-Abellán P, Deben G, Alonso N, Blanes M, Rodríguez MJ, Nicolás C, Sánchez E, Fernández de Sevilla A, Conde E, Ribera JM; QUIT Study (PETHEMA, GELTAMO and GOTEL Groups).

Med Clin (Barc). 2008 Oct 4;131(11):401-5.

PMID:
18928719
5.

Seizures following intrathecal cytosine arabinoside in young children with acute lymphoblastic leukemia.

Eden OB, Goldie W, Wood T, Etcubanas E.

Cancer. 1978 Jul;42(1):53-8.

PMID:
276417
6.

Myelopathy following intrathecal chemotherapy in adults: a single institution experience.

Cachia D, Kamiya-Matsuoka C, Pinnix CC, Chi L, Kantarjian HM, Cortes JE, Daver N, Woodman K.

J Neurooncol. 2015 Apr;122(2):391-8. doi: 10.1007/s11060-015-1727-z. Epub 2015 Feb 10.

8.

Paraparesis following intrathecal cytosine arabinoside: a case report with neuropathologic findings.

Breuer AC, Pitman SW, Dawson DM, Schoene WC.

Cancer. 1977 Dec;40(6):2817-22.

PMID:
271037
9.

Dose intensification of methotrexate and cytarabine during intensified continuation chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: POG 9406: a report from the Children's Oncology Group.

Tower RL, Jones TL, Camitta BM, Asselin BL, Bell BA, Chauvenet A, Devidas M, Halperin EC, Pullen J, Shuster JJ, Winick N, Kurtzberg J.

J Pediatr Hematol Oncol. 2014 Jul;36(5):353-61. doi: 10.1097/MPH.0000000000000131.

10.
11.
12.

Progressive ascending paralysis following administration of intrathecal and intravenous cytosine arabinoside. A Pediatric Oncology Group study.

Dunton SF, Nitschke R, Spruce WE, Bodensteiner J, Krous HF.

Cancer. 1986 Mar 15;57(6):1083-8.

PMID:
3455842
13.

Childhood-onset chronic inflammatory demyelinating polyradiculoneuropathy with cranial nerve involvement.

Costello F, Lee AG, Afifi AK, Kelkar P, Kardon RH, White M.

J Child Neurol. 2002 Nov;17(11):819-23. Erratum in: J Child Neurol. 2003 Mar;18(3):179.

PMID:
12585721
14.

Tumor Lysis Syndrome (TLS) following intrathecal chemotherapy in a child with acute myelogenous leukemia (AML).

Glasser CL.

Leuk Res Rep. 2017 Oct 23;8:19-20. doi: 10.1016/j.lrr.2017.10.002. eCollection 2017.

15.

Secondary adrenal insufficiency in an infant after intrathecal triple chemotherapy.

Seif AE, Sutter JA, Rheingold SR.

Pediatr Blood Cancer. 2010 Aug;55(2):386-9. doi: 10.1002/pbc.22533.

PMID:
20582966
16.

Transverse myelopathy following intrathecal administration of chemotherapy.

Teh HS, Fadilah SA, Leong CF.

Singapore Med J. 2007 Feb;48(2):e46-9.

17.
18.

Oculomotor nerve invasion of acute myelogenous leukemia demonstrated by magnetic resonance imaging.

Tabata M, Yoshida M, Takahashi H, Toshima M, Takatoku M, Tsunoda J, Kikuno M, Hatake K, Miura Y.

Leuk Lymphoma. 1998 Jul;30(3-4):411-4.

PMID:
9713972
19.
20.

Acute tumor lysis syndrome following intrathecal methotrexate.

Benekli M, Güllü IH, Savaş MC, Kadayifçi A, Altundağ MK, Tekuzman G, Firat D.

Leuk Lymphoma. 1996 Jul;22(3-4):361-3.

PMID:
8819088

Supplemental Content

Support Center